Skip to main content

Table 3 Allele frequency distribution of FNDC5 rs16835198 alleles according to APOE ε2/ε4 status in the study population

From: Epistasis, physical capacity-related genes and exceptional longevity: FNDC5 gene interactions with candidate genes FOXOA3 and APOE

FNDC5 (rs16835198)allele

 

Absence of APOE ε4-allelea

Presence of APOE ε4-allelea

  

Controls (2n = 1306)

Centenarians (2n = 1340)

Controls (2n = 336)

Centenarians (2n = 128)

G

N

570

648

165

62

%

43.6%

48.4%

49.1%

48.4%

P-value

0.0167

NS

OR (95% CI)

1.21 (1.04, 1.41)

T

N

736

692

171

66

%

56.4%

51.6%

50.9%

51.6%

P-value

0.0167

NS

OR (95% CI)

0.83 (0.71–0.96)

FNDC5 (rs16835198)allele

 

Absence of APOE ε2-allelea

Presence of APOE ε2-allelea

  

Controls (2n = 1508)

Centenarians (2n = 1258)

Controls (2n = 134)

Centenarians (2n = 210)

G

n

685

607

50

103

%

45.4%

48.3%

37.3%

49%

P-value

NS

0.035

OR (95% CI)

1.62 (1.04–2.52)

T

n

823

651

84

107

%

54.6%

51.7%

62.7%

51%

P-value

NS

0.035

OR (95% CI)

0.62 (0.40–0.96)

  1. Abbreviations: 95%CI 95% confidence interval, NS not significant, OR odds ratio
  2. aAll individuals underwent genotyping for rs429358 and rs7412. The 3 major isoforms of human APOE gene (E2, E3, and E4) coded by 3 alleles (ε2, ε3, and ε4) differ in amino acid sequence at 2 sites, residue 112 (rs429358) and residue 158 (rs7412)